European Urology published a clinical update in Research Highlights on 18 Feb 2026. The item focuses on Corrigendum to “Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-Guérin (BCG) in BCG-naïve High-risk Non–muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC Trials” [Eur.
Urol. (2025)].
Review the original article for the full source wording and details.
European Urology published a clinical update in Research Highlights on 18 Feb 2026.
The item focuses on Corrigendum to “Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-Guérin (BCG) in BCG-naïve High-risk Non–muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC Trials” [Eur.
Urol.
(2025)].
Review the original article for the full source wording and details.